YUKA (Yuka Group) Notes Receivable: $0.00 Mil (As of Sep. 2014)


What is Yuka Group Notes Receivable?

Yuka Group YUKA -1.92% Notes Receivable is $0.00 Mil as of Sep. 2014.

Yuka Group's Notes Receivable for the quarter that ended in Sep. 2014 was $0.00 Mil.

Yuka Group Notes Receivable Historical Data

* Premium members only.

The historical data trend for Yuka Group's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yuka Group Notes Receivable Chart

Yuka Group Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Yuka Group Quarterly Data
Dec09 Dec10 Mar11 Jun11 Sep11 Dec11 Sep12 Dec12 Mar13 Jun13 Dec13 Mar14 Jun14 Sep14
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Yuka Group Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Yuka Group (YUKA) has a Notes Receivable of $0.00 Mil as of Sep. 2014. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Yuka Group and its competitors.
Is Yuka Group's Notes Receivable too high?
Yuka Group's current Notes Receivable is $0.00 Mil.
How does Yuka Group's Notes Receivable compare to ESTRF and HALN?
Yuka Group's Notes Receivable of $0.00 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Retail - Cyclical company?
A good Notes Receivable depends on the Retail - Cyclical industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Yuka Group and its competitors. Yuka Group's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yuka Group stock overvalued right now?
Yuka Group (YUKA) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Yuka Group (YUKA), the current Notes Receivable is $0.00 Mil as of Sep. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yuka Group Business Description

Address 20801 Biscayne Boulevard, Suite 403, Aventura, FL, USA, 33180
Yuka Group Inc is a holding company which operates through its subsidiary. It is a health care provider that provides products and services using edge specialized medical equipment, prescription medications, supplements, peptides, stem-cells, etc. to help patients with areas of their life that traditional medical doctors who are focused on sick care do not address. These areas include but are not limited to anti-aging medicine, esthetics, weight loss, increased energy, erectile dysfunction treatments, etc.